ArticleFrontiers in oncology2022

Inconsistent clinical outcomes following afatinib treatment in NSCLC patients harboring uncommon epidermal growth factor receptor mutation.

Wei Dong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.